STVNNYSESurgical & Medical Instruments & Apparatus

Stevanato Group S.p.A.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 4, 2026

$19.02+0.12 (+0.63%)

Close on Oct 19, 2026

Community

Notes and questions about Stevanato Group S.p.A. from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Stevanato Group S.p.A.'s annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is STVN.

Revenue growth7.4% · median 10.2%

Gross margin29.0% · median 52.5%

Operating margin16.8% · median 12.8%

Net margin11.8% · median 8.6%

Advertisement
300 × 250